JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB124690

Anti-ARL4A antibody [EPR6086]

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal ARL4A antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.

View Alternative Names

ARL4, ARL4A, ADP-ribosylation factor-like protein 4A

2 Images
Western blot - Anti-ARL4A antibody [EPR6086] (AB124690)
  • WB

Lab

Western blot - Anti-ARL4A antibody [EPR6086] (AB124690)

We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.

Blocking/Diluting Buffer and concentration : 5% NFDM/TBST

All lanes:

Western blot - Anti-ARL4A antibody [EPR6086] (ab124690) at 1/1000 dilution

All lanes:

Human small intestine tissue lysate prepared in 1% SDS Hot lysis method at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

OI-RD Scanning - Anti-ARL4A antibody [EPR6086] (AB124690)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-ARL4A antibody [EPR6086] (AB124690)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • Carrier free

    Anti-ARL4A antibody [EPR6086] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR6086

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Complementary Products

Primary Antibodies

AB92547

Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker

BOND RX™ Validated|KO Validated|RabMAb|Recombinant|Lab Essentials|20ul selling size|Advanced Validation

Multiplex immunohistochemistry - Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (AB92547)

  • 5
  • 92
Primary Antibodies

AB315340

Anti-BCMA antibody [EPR28583-5]

BOND RX™ Validated|20ul selling size|RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BCMA antibody [EPR28583-5] (AB315340)

  • 0
  • 0
Primary Antibodies

AB92506

Anti-STAT1 alpha antibody [EPYR2154]

BOND RX™ Validated|20ul selling size|RabMAb|Recombinant|KO Validated|Advanced Validation

Immunoprecipitation - Anti-STAT1 alpha antibody [EPYR2154] (AB92506)

  • 4
  • 2
Primary Antibodies

AB198738

Anti-Thymosin beta 10 antibody - C-terminal

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Thymosin beta 10 antibody - C-terminal (AB198738)

  • 0
  • 0
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ARL4A (ADP-Ribosylation Factor-Like 4A) acts as a small GTPase in the ADP-ribosylation factor family. This protein also known as ARF-like protein has a mass of approximately 20 kDa. ARL4A is expressed in various tissues including the brain and kidneys. It plays an important role in intracellular signaling impacting cytoskeleton dynamics and membrane trafficking.
Biological function summary

ARL4A impacts cellular processes through its involvement in actin cytoskeleton reorganization. This makes ARL4A important in cell migration and morphogenesis. As part of the ARF family ARL4A may interact with other small GTPases forming a signaling complex that modulates cellular function. Its activity helps maintain cell structure and movement reflecting its influence on morphogenetic processes.

Pathways

ARL4A participates in signal transduction networks like the Ras-related pathways. It links to proteins such as ARF6 showing its involvement in vesicular trafficking and cytoskeleton remodeling. Through these pathways ARL4A helps coordinate intracellular activities that maintain cell shape and adhesion contributing to overall cellular dynamics.

ARL4A links to pathological conditions like cancer and metabolic disorders. Abnormal ARL4A expression associates with oncogenic processes suggesting its influence on tumorigenesis. Additionally disruptions in ARL4A function might involve interactions with proteins like ARL6 indicating potential metabolic dysregulation. These connections highlight ARL4A's significance in disease development and progression marking it as an important target in disease research.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. Recruits CYTH1, CYTH2, CYTH3 and CYTH4 to the plasma membrane in GDP-bound form.
See full target information ARL4A
style
left-column

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

MedComm 6:e70148 PubMed40151835

2025

Transforming Growth Factor Beta2 Promotes Migration and Inhibits the Proliferation of Gastric Cancer Cells by Regulating the pSmad2/3-NDRG1 Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Feng-Jun He,Xiao-Long Chen,Yun-Feng Zhu,Hua-Yang Pang,Ze-Dong Li,Pan-Ping Liang,Tao Jin,Zheng-Wen Chen,Ze-Hua Chen,Jian-Kun Hu,Kun Yang
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com